AxoGen, Inc.
AXGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 6% | 16.7% | -1.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 76.6% | 74.2% | 71.9% | 76.1% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 21.1% | 7.7% | 0.6% | 8.4% |
| Net Income | $0 | $0 | -$0 | $0 |
| % Margin | 1.2% | 1% | -7.9% | 0.9% |
| EPS Diluted | 0.013 | 0.012 | -0.085 | 0.009 |
| % Growth | 5% | 114.3% | -1,002.1% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |